REQUEST A DEMO
Total
USD $0.00
Search more companies

Chirana T. Injecta, S.R.O. (Czech Republic)

Main Activities: Medical Equipment and Supplies Manufacturing
Full name: Chirana T. Injecta, S.R.O. Profile Updated: October 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Chirana T. Injecta, S.R.O. is an enterprise based in Czech Republic. Its main office is in Prague. The company operates in the Medical Equipment and Supplies Manufacturing industry. The company was established on June 15, 2000. It currently has a total number of 100 - 199 (2024) employees. There was a net sales revenue increase of 7.71% reported in Chirana T. Injecta, S.R.O.’s latest financial highlights for 2023. During that time, Chirana T. Injecta, S.R.O.’s total assets grew by 34.73%. In 2023, Chirana T. Injecta, S.R.O.’s net profit margin increased by 2.78%.

Headquarters
Komoranska 2148
Prague; The City of Prague; Postal Code: 14300

Contact Details: Purchase the Chirana T. Injecta, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Chirana T. Injecta, S.R.O. report to view the information.
Outstanding Shares:
Purchase the Chirana T. Injecta, S.R.O. report to view the information.
Registered Capital:
Purchase the Chirana T. Injecta, S.R.O. report to view the information.
Incorporation Date:
June 15, 2000
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
98.99%
Purchase this report to view the information.
1.01%
Company Performance
Financial values in the chart are available after Chirana T. Injecta, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
7.71%
Total operating revenue
7.17%
Operating profit (EBIT)
30.5%
EBITDA
36.58%
Net Profit (Loss) for the Period
29.14%
Total assets
34.73%
Total equity
30.9%
Operating Profit Margin (ROS)
3.78%
Net Profit Margin
2.78%
Return on Equity (ROE)
-0.33%
Debt to Equity Ratio
16.9%
Quick Ratio
0.54%
Cash Ratio
0.47%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?